- Home
- SUPX vs PRLD Comparison
SUPX vs PRLD Comparison
Compare SUPX & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SUPX | PRLD |
|---|---|---|
| Founded | 2021 | 2016 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 273.3M | 260.2M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SUPX | PRLD |
|---|---|---|
| Price | $5.23 | $3.82 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $9.20 |
| AVG Volume (30 Days) | 254.5K | ★ 313.4K |
| Earning Date | 11-24-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.21 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,140,000.00 |
| Revenue This Year | N/A | $220.54 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 73.43 |
| 52 Week Low | $4.11 | $1.30 |
| 52 Week High | $49.99 | $6.83 |
Technical Indicators
Market Signals| Indicator | SUPX | PRLD |
|---|---|---|
| Relative Strength Index (RSI) | 39.51 | 48.40 |
| Support Level | $4.11 | $3.38 |
| Resistance Level | $7.40 | $4.12 |
| Average True Range (ATR) | 0.60 | 0.35 |
| MACD | -0.03 | 0.03 |
| Stochastic Oscillator | 46.12 | 49.45 |
Price Performance
Historical ComparisonAbout SUPX Super X AI Technology Limited Ordinary Shares
Super X AI Technology Ltd is an AI infrastructure solutions provider. Through its subsidiaries, SuperX offers a comprehensive portfolio of proprietary hardware, advanced software, and end-to-end services for AI data centers. The Company's services include advanced solution design and planning, cost-effective infrastructure product integration, and end-to-end operations and maintenance. Its core products include high-performance AI servers, High-Voltage Direct Current (HVDC) solutions, high-density liquid cooling solutions, as well as AI cloud and AI agents. The Company serves institutional clients globally, including enterprises, research institutions, and cloud and edge computing deployments.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.